Aatmaj Health

- Currently, there is no immediate plan to raise further funds through debt or equity. - The Managing Director, Dr. Tushar Suvagiya, stated that he has not thought about raising further funds at present. - Future capital expenditure, such as for IVF centers and potential onco-radiation units, will require significant investment (around Rs. 4-5 crores for IVF centers alone). - The company is focusing on growth through strategic acquisitions and partnerships rather than immediate fundraising. - Any decision on future fundraising will depend on business expansion needs and capital requirements, especially for high-cost ventures like onco-radiation therapy. (Reference: Page 7 and Page 5-6 excerpts from the transcript)

- Recent CapEx was incurred to increase bed capacity from 130 to 330 beds, primarily through strategic acquisitions and leases rather than owning properties, minimizing capital outlay. - No plans to invest in building ownership going forward; existing newly acquired hospitals are on rental/lease agreements. - Planned CapEx of around ₹4-5 Cr over the next year for setting up 2 IVF centers, including equipment and operational costs. - IVF centers expected to start before March 2024; potential for partnership or takeover of existing centers. - Expansion plan includes increasing capacity to 430 beds and growing presence in Gujarat, Rajasthan, Madhya Pradesh, and Maharashtra. - High-capital projects like oncology radiation therapy (costing ~₹16 Cr) are currently on hold due to financial prudence. - No immediate plans for further fund raising for capital investments; focus is on organic growth and acquisitions.

- Target revenue for current year (FY 23-24): Around Rs. 28 to 32 crore, depending on PMJAY strategy. - Projected revenue in 2-3 years (FY 25-26): Around Rs. 80 to 90 crore. - Expected revenue for next year: Approximately Rs. 45 to 50 crore. - Growth driven by strategic acquisitions of multi-specialty hospitals and expansion into new verticals like IVF centers. - Expansion plan includes increasing bed capacity from current 330 beds to 430 beds. - Geographic expansion planned in four states: Gujarat, Madhya Pradesh, Rajasthan, and Maharashtra by 2027. - Focus on high-margin services such as IVF centers starting before the end of the current financial year. - Emphasis on maintaining 20% net profit margin as turnover increases, though margins may vary with scale.

- Projected turnover for current year: around Rs. 30 crore - Expected turnover in 2-3 years: Rs. 80 to 90 crore - Anticipated turnover next year (approximate): Rs. 45 to 50 crore - Net profit margin expected to be around 20% as turnover scales up - EBITDA margin currently strong at 46.7% with PAT margin at 25.9% in H1 FY '24 - Future growth driven by strategic acquisitions, bed capacity expansion (from 330 to 430 beds), and new verticals like IVF centers - IVF centers anticipated to start before March 2024, expected to generate high revenue and profit - Operating margin expected to be maintained in future due to focused business model and cost control - Expansion planned in four states (Gujarat, Madhya Pradesh, Rajasthan, Maharashtra) over next 2-3 years - No immediate plans for further fund raising; focus on efficient management and organic growth

- The transcript does not explicitly mention the current or expected order book or pending orders. - The focus is primarily on hospital acquisitions, expansions, and revenue projections rather than specific order books. - The company has recently expanded bed capacity from 130 to 330 beds, aiming for 430 beds. - Future growth strategies include expanding in states like Rajasthan, Madhya Pradesh, Gujarat, Maharashtra, and launching IVF centers. - Revenue projections for the next 2-3 years are around Rs. 80-90 crores, with a 20% net profit margin aimed. - No direct reference to an order book or pending orders is provided in the available transcript content.